J Neurosci by McIntire, Laura Beth J. et al.
Reduction of Synaptojanin1 Ameliorates Synaptic and
Behavioral Impairments in a Mouse Model of Alzheimer’s
Disease
Laura Beth J. McIntire1,*, Diego E. Berman1,*, Jennifer Myaeng1, Agniezka Staniszewski1,
Ottavio Arancio1, Gilbert Di Paolo1,¶, and Tae-Wan Kim1,¶
1Department of Pathology and Cell Biology and Taub Institute for Research on Alzheimer’s
Disease and the Aging Brain, Columbia University Medical Center, New York, NY, 10032
Abstract
Decades of research have correlated increased levels of amyloid β-peptide (Aβ) with
neuropathological progression in Alzheimer’s disease (AD) patients and transgenic models. Aβ
precipitates synaptic and neuronal anomaliesby perturbing intracellular signaling which, in turn,
may underlie cognitive impairment. Aβ also alters lipid metabolism, notably causinga deficiency
of phosphatidylinositol 4,5-bisphosphate [PI(4,5)P2], a phospholipid that regulates critical
neuronal functions. Haploinsufficiency of the gene encoding synaptojanin 1 (Synj1), a major
PI(4,5)P2 phosphatase in the brain, provided protection against PI(4,5)P2 breakdown and
electrophysiological deficits attributable to Aβ. Based on these data, we tested whether reduction
of Synj1 could rescue cognitive deficits and Aβ-induced morphological alterations of synapses.
We found that hemizygous deletion of Synj1 in the context of a mouse model expressing the
Swedish mutant of amyloid precursor protein rescues deficits in learning and memory without
affecting amyloid load. Synj1 heterozygosity also rescued PI(4,5)P2 deficiency in a synaptosome-
enriched fraction from the brain of Tg2576 mice. Genetic disruption of Synj1 attenuated Aβ
oligomer-induced changes in dendritic spines of cultured hippocampal neurons, sparing
maturespine classes, which corroborates the protective role for Synj1 reduction against Aβ insult
at the synapse. These results indicate that Synj1 reduction ameliorates AD-associated behavioral
and synaptic deficits, providing evidence that Synj1 and, more generally, phosphoinositide
metabolism, may be promising therapeutic targets. Our work expands on recent studies identifying
lipid metabolism and lipid modifying enzymes as targets of AD-associated synaptic and
behavioral impairment.
Introduction
A pathogenic hallmark of Alzheimer’s disease (AD) is the cleavage of amyloid precursor
protein (APP) leading to accumulation of amyloid β-peptide (Aβ) and subsequent deposition
in plaques (Bertram and Tanzi, 2012). Accumulation of soluble Aβ oligomers closely
correlates with cognitive decline and disease progression in animal models and AD patients
primarily through disruption of synaptic plasticity (Benilova et al., 2012). Soluble Aβ
oligomers also profoundly alter dendritic spine morphology in dissociated cultures,
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hippocampal slices and in animal models of AD (Pozueta et al., 2012). While these synaptic
defects can be modulated by altering glutamatergic receptor trafficking and actin
cytoskeleton dynamics (Pozueta et al., 2012), the molecular mechanisms orchestrating
downstream effects of Aβ oligomers remain poorly understood.
Recent work has indicated that perturbation ofphosphatidylinositol-4,5-bisphosphate
[PI(4,5)P2] may be relevant to the synaptotoxic actions of Aβ oligomers and more generally
to AD (Landman et al., 2006; Berman et al., 2008; Di Paolo and Kim, 2011). The catabolism
of PI(4,5)P2, a signaling lipid critical for ion channel regulation, exo/endocytosis, actin
cytoskeleton rearrangement and signal transduction, is tightly controlled by the
polyphosphoinositide phosphatase, synaptojanin1 (Synj1) (Di Paolo and De Camilli, 2006).
Synj1 plays a critical role in synaptic vesicle trafficking, actin dynamics and AMPAR
internalization (Di Paolo and De Camilli, 2006; Gong and De Camilli, 2008). Neurons
derived from mice deficient in PI(4,5)P2 dephosphorylation due to haploinsufficiency of the
gene encoding Synj1 (Synj1) display resistance to Aβ42 oligomer effectson PI(4,5)P2
destabilization and electrophysiological synaptic impairment (c). Recent work has further
connected phosphoinositide metabolism to AD by identification of the Synj1 ortholog,
INP52, in anunbiased genome-wide screen for Aβ toxicity modifiers in yeast (Treusch et al.
2011). Further, Synj1 displayed transcriptional changes in a mouse model of AD and in AD
patients (Miller et al., 2008; Alldred et al., 2012). Altogether, these studies suggest that
PI(4,5)P2 imbalance may play a critical role in AD pathogenesis.
In this study, we show that Synj1 haploinsufficiency protects against memory impairment in
an AD mouse model, Tg2576 (Hsiao, 1996). To address the underlying cause of this
behavioral rescue, we examined morphological changes in dendritic spines triggered by Aβ




Synj1+/− mice (Cremona et al., 1999) were bred to Tg2576 (Hsiao et al., 1996, Taconic) to
create Tg2576/Synj1 F1 progeny. Since Synj1−/− mice do not survive to adulthood, Synj1+/−
mice were used, giving rise to four genotypes:Synj1+/+, Synj1+/−, Tg2576/Synj1+/+and
Tg2576/Synj1+/−. Both sexes were used for experiments, but no gender specific defects were
found.
Fear conditioning (FC)
Contextual FC is a hippocampus/amygdala-dependent task in which Tg2576 mice show
deficits (Barnes et al., 2005). The test was performed on 5–6 month old mice as previously
described and cued FC, a hippocampus-independent task, was used as a control (Oliveira et
al., 2010).
Two-day radial arm water maze (2-day RAWM)
SinceTg2576 mice show deficits in reference memory in the 2-day RAWM, 7–8 month old
mice were tested as previously described (Alamed et al, 2006).
Novel object recognition task (NOR)
Tg2576 mice show deficits in the NOR memory task (Hernandez et al., 2010). Littermates at
5–6 months of age were tested in NOR and onset of the exploration time was defined as the
moment the head of the animal approached the object within a 2.5cm radius.
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Western analysis was accomplished using antibodies to Synj1 (Haffner et al., 1997),
neuronal β-tubulin (TUJ1, Covance)and human APP (6E10, Covance). Synj1 was quantified
using Fugifilm LAS3000 and MultiGaugev3.0 imaging software and APP was quantified
using Licor Odyssey infrared detection. For quantification of Aβ40 and Aβ42 (ELISA,
Invitrogen) brain tissue was processed as previously described (Schmidt et al., 2005).
Lipid analysis
To quantify phosphoinositide levels in brain tissue, HPLC combined with suppressed
conductivity detection was used (Berman, et al., 2008). The crude synaptosome fraction (P2)
was isolated from brains prior to lipid extraction (Wu, et al., 1986).
Dendritic spine analysis in cultured primary neurons
Hippocampal primary cultures were prepared from neonatal pups (Berman et al., 2008) and
cultured for 21 days. Cultures were exposed to 200nM Aβ oligomer for 24 hours, fixed with
4% paraformaldehyde and DiOlistically labeled with Dil (Molecular Probes, Smith et al.,
2009). Images were collected with 100x objective and 3.14x zoom using a z-stack of 0.3μm
sections on a Nikon C1 digital confocal system attached to an Olympus IX71 inverted scope.
Neuron Studio (Rodriguez et al., 2008) was used to analyze spine density and spine class.
Statistical methods
For analysis of behavioral tests, one-way ANOVA was used with Tukey’s Multiple
Comparison Test except for FC data, which were not normally distributed. The non-
parametric Kruskal-Wallis test was used to analyze contextual FC data (p = 0.056). There
were no significant differences between the groups at baseline, pre-cue or post-cue freezing
using the Kruskal-Wallis test. In order to better fit the normality assumptions of ANOVA,
the contextual FC data were transformed using Log10 and re-analyzed using one-way
ANOVA (p = 0.045). One-way ANOVA and Tukey’s Multiple Comparison Test were used
for the phospholipid analysis. Student’s t-test was used for all other biochemical
experiments and spine analysis using 2-tailed distribution with equal variance (p < 0.05). All
data are shown as geometric mean ± SEM.
Results
Cognitive rescue in Tg2576/Synj1+/− mice
To investigate the effects of hemizygous deletion of Synj1 on learning and memory
impairment, we employed a battery of three behavioral tests, contextual FC, two-day
RAWM and NOR. In contextual FC, a hippocampus- and amygdala-dependent learning task
(Maren, 2008), Tg2576 mice exhibit deficits at 5–6 months of age which precedes amyloid
plaque deposition (Hsiao et al., 1996; Oliveira et al., 2010). While Tg2576/Synj1+/+ showed
decreased freezing and thus impaired contextual fear memory when exposed to the
conditioning context 24h after training, Tg2576/Synj1+/− mice showed normal freezing as
their wild type (WT) and Synj1+/− littermates (Fig. 1A). In contrast to contextual FC,
auditory cued FC, a hippocampus-independent task, showed no differences among
genotypes (Fig. 1B).
The2-day RAWM taske valuates reference memory by scoring entry into a maze arm
without the escape platform as an error. Tg2576 mice typically show impaired ability to
learn which arm of the maze has the escape platform (Alamed et al., 2006). Accordingly,
Tg2576/Synj1+/+ mice did not effectively learn to locate the escape platform. In contrast,
WT, Synj1+/−, and importantly, Tg2576/Synj1+/− mice showed a progressive decrease in
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errors over the course of the experiment, indicating that they had learned the task (Fig. 1C).
The visible platform task was used to evaluate potential baseline differences in sensory or
motor performance or motivation between genotypes. Some Tg2576/Synj1+/+ mice avoided
the visible platform due to neophobia (session 2–3), but the difference in latency was
abolished by trial 4 (Fig. 1D, Alamed et al., 2006). Additionally, there were no consistent
differences in the mouse swim speed (Fig. 1E).
Published studies have shown that Tg2576 mice exhibit NOR deficits (Hernandez et al.,
2010). All mice explored both objects equally on the training day (Fig. 1F). As expected, on
the testing day (Fig. 1G), Tg2576/Synj1+/+ mice spent the same amount of time with each
object indicating they were unable to discriminate between the novel and original objects.
Tg2576/Synj1+/− animals, however, displayed the same exploratory behavior as WT and
Synj1+/− mice, spending more time with the novel object. Consistent with published results
(Gil-Bea et al., 2007), we observed hyperlocomotor activity of Tg2576 mice in the open
field test of NOR testing and this phenotype was rescued in the Tg2576/Synj1+/− mice (Fig.
1H). Thus, three separate behavioral tests revealed that reduction of Synj1 in Tg2576 mice
was sufficient to ameliorate deficits in learning and memory.
Effect of hemizygous deletion of Synj1 on Aβand phosphoinositide levels in a mouse
model of AD
We investigated the possibility that haploinsufficiency of Synj1 may affect Aβ and
phosphoinositide levels in the AD model. Western blot analysis showed no differences in
the levels of the transgene, human APPsw, in Tg2576/Synj1+/+ and Tg2576/Synj1+/− mice
(Fig. 2A, B). In both the haploinsufficient genotypes, Synj1+/− and Tg2576/Synj1+/−, Synj1
protein levels were reduced compared toSynj1+/+ and Tg2576/Synj1+/+ genotypes (Fig. 2A,
C). Neither Aβ42 nor Aβ40 levels were affected by haploinsufficiency of Synj1 (Fig. 2D).
Importantly, the levels of PI(4,5)P2, but not control inositol lipids phosphatidylinositol (PI)
and phosphatidylinositol-4-phosphate (PI4P), were significantly reduced in the
synaptosome-enriched (P2) fraction from forebrain tissue of Tg2576mice and restored to
wild-type levels in Tg2576/Synj1+/− mice (Fig. 2E). Interestingly, these changes were
observed in synaptosome-enriched fractions, but not in whole forebrain extracts (data not
shown), suggesting that alterations in PI(4,5)P2 in the Tg2576 model may besynapse-
specific.
Effect of Synj1 reduction on Aβ-induced changes in dendritic spine morphology
To investigate the underlying cause of the observed behavioral rescue due to reduced Synj1
and PI(4,5)P2 maintenance, we investigated the effects of Synj1 reductionon structural spine
modifications caused by soluble Aβ oligomers. Dendritic spines, which are protrusions on
dendritic processes of excitatory neurons, undergo dynamic structural changes that are
closely associated with learning and memory (Bosch and Hayashi, 2012) and are profoundly
affected by Aβ oligomers (Pozueta et al., 2012). We analyzed spine morphology in
dissociated hippocampal primary cultures of Synj1+/+, Synj1+/−or Synj1−/− mice. Under
basal conditions, density and head diameter were not altered among the genotypes though in
Synj1+/− andSynj1−/− neurons, dendritic spines were significantly longer (Fig. 3A–D). Prior
studies have reported decreased spine density and increased spine length after treatment of
cultured neurons with Aβ oligomers (Calabrese et al., 2007; Lacor et al., 2007), both of
which were recapitulated in wild type neurons treated with Aβ (Fig. 3A–C). However, in
Synj1+/− and Synj1−/− neurons, density was preserved and spine length did not increase
following treatment with Aβ oligomers (Fig. 3A–C). When spines were analyzed by class,
we observed stubby and thin spines in Synj1+/− and Synj1−/−neurons were selectively spared
from Aβ oligomer-induced decrease in density (Fig. 3A, E). Furthermore, in Synj1−/−
neurons, mushroom spines were spared in addition to thin and stubby spines (Fig. 3A, E).
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These results support the hypothesis that neuronswith reduced levels of Synj1 are fortified
against synaptic defects induced by Aβ oligomers.
Discussion
We previously identified PI(4,5)P2 metabolism as a target of familial AD-linked presenilin
mutations and Aβ oligomers (Landman et al., 2006; Berman et al., 2008; Di Paolo and Kim,
2011). Haploinsufficiencyof Synj1 was found to cause a decrease in the dephosphorylation
of brain PI(4,5)P2 (Voronov et al., 2008) and conferred protection against Aβ-induced
defects in long-term potentiation (Berman et al., 2008). In this study, we investigated the
role Synj1 reduction plays in behavioral deficits in a mouse model of A Das well as
morphological alterations in dendritic spines triggered by Aβ oligomers. We found that
Synj1 haploinsufficiency was sufficient to ameliorate learning and memory deficits in the
Tg2576mouse model of AD in three independent behavioral paradigms, contextual FC,
RAWM and NOR. Because Tg2576 animals do not develop extensive plaque pathology in
the age group we studied (5–9 months), their learning deficits are likely due to the
accumulation of soluble pools of Aβ (Hsiao et al., 1996). However, Aβ levels were
unaltered by the reduction of Synj1 suggesting that the protective effects on behavior are
independent of Aβ levels in Tg2576/Synj1+/− mice, likely reflecting interference with Aβ-
induced synaptotoxic signaling. Because our previous work showed Aβ42 oligomers cause a
decrease in PI(4,5)P2, the major substrate for Synj1 (Berman et al, 2008), we investigated
PI(4,5)P2metabolism in our in vivo models. Though we found no global reduction of
PI(4,5)P2 levels in whole forebrain extracts, synaptosome-enriched (P2) fractions displayed
reduced PI(4,5)P2 levels in Tg2576 mice but notinTg2576/Synj1+/− mice. This supports the
hypothesis that synaptic pools of PI(4,5)P2 are affected by Aβ and preserved by the absence
of one copy of Synj1 in this mouse model. Interestingly, despite reports indicating Aβ
biogenesis and APP processing are modulated by PI(4,5)P2 (Landman et al., 2006; Osawa et
al., 2008; Osenowski et al., 2008), we found no alterations in full-length APP, Aβ40 or
Aβ42levels in the Tg2576/Synj1+/− cross, suggesting that specific pools of
PI(4,5)P2involved in APP processing may not be affected by the partial reduction of Synj1
in the context of APPsw overexpression.
To understand the cellular mechanism underlying the protective role of Synj1 deficiency, we
investigated changes in spine morphology after Aβ insult. Cultured hippocampal neurons
with reduced Synj1 maintained normal spine density, length and mature classes of spines,
namely mushroom, thin and stubby, in the presence of Aβ oligomer. One possible
mechanism underlying maintenance of spine morphology in the presence of Aβ challenge,
as well as amelioration of the learning and memory deficits, is regulation of synaptic
glutamate receptor trafficking which has been shown to affect spine morphology under non-
pathological conditions (Kopec et al., 2006) and to be sensitive to Aβ (Pozueta et al., 2012).
Importantly, a recent study has demonstrated that ablation ofSynj1 delays AMPA receptor
(AMPAR) internalization (Gong and De Camilli, 2008). Reduction of Synj1 and resulting
PI(4,5)P2 maintenance may thus delay the loss of AMPAR from the synaptic membrane due
to Aβ challenge, thereby preserving spine morphology and synaptic function. It has also
been reported that the NMDA receptor (NMDAR) interacts with PI(4,5)P2 through α-
actinin, an actin crosslinking protein (Michailidis et al., 2007), and PI(4,5)P2-mediated
regulation of NMDAR trafficking is impaired by Aβ challenge (Mandal and Yan, 2009).
Since Aβ has been reported to decrease NMDAR surface expression (Pozueta et al., 2012),
reduction of Synj1 could prevent this phenomenon through maintenance of
PI(4,5)P2resulting in more persistent NMDAR signaling. Synj1 may also have a role
downstream of Aβ signaling as a substrate of calcineurin, a Ca2+-activated phosphatase that
controls synaptic plasticity and has been shown to stimulate Synj1 via dephosphorylation
(Lee et al., 2004). Indeed, calcineurinsignaling has been shown to mediate Aβ-induced spine
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loss (Shankar et al., 2007), raising the possibility that a relevant target of this phosphatase
downstream of Aβmay be Synj1. Finally, reduced Synj1 levels may maintain synaptic pools
of PI(4,5)P2 preventing actin destabilization, which has been previously reported to occur in
response to Aβ oligomer treatment (Shankar et al., 2007).
Overall, our studies validate Synj1 at the genetic level as a candidate therapeutic target for
AD. Since Aβ-lowering strategies targeting late-stage AD have had only modest success in
recent clinical trials (Huang and Mucke, 2012), identification of alternate targets that are
independent of amyloid load, such as Synj1, is critical for progress in the development of
AD therapeutics. Our data revealed that heterozygous deletion of the Synj1 gene ameliorates
AD-associated cognitive deficits and protects synapses against Aβ, without interfering with
normal behavior or synaptic function. Thus, reducingSynj1 levels may give rise to the
desired protective phenotype without interfering with normal brain function in AD patients.
Reducing Synj1 activity may also be beneficial in ameliorating the cognitive deficits of
Down syndrome, characterized by over expression of genes on chromosome 21, including
Synj1 and App, and inevitably leading to AD pathology in adulthood (Voronov et al., 2008
and Cossec et al., 2012). Confluent with a validated therapeutic target for diabetes,
phosphoinositide phosphatases represent a new and promising class of therapeutic targets in
human diseases (McCrea and De Camilli, 2009). In addition to phosphatases, a
phosphoinositide kinase has also been implicated in AD pathology. Inhibition ofPI3-kinase
has been demonstrated to decrease Aβ biogenesis (Petanceska et al., 1999 and Haugabook et
al. 2001) and ameliorate AD-associated cognitive defects (Chiang et al., 2010). Finally,
recent work has shown that genetic disruption of phospholipases, such as phospholipase D2
and cytosolic phospholipase A2, improves pathological phenotypes in AD mouse models
(Oliveira et al., 2010; Sanchez-Mejia et al., 2010; and Chan et al., 2012). Collectively, these
studies substantiate that modulation of neuronal lipid networks can ameliorate AD-
associated pathologies and therefore targeting lipid-modifying enzymes represents an
engaging strategy for future development of AD therapeutics.
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Hemizygous deletion of Synj1 ameliorates memory and behavioral deficits in Tg2576 mice.
A, Freezing response in the FC paradigm in 5–6 month old WT (n=12), Synj1+/− (n=16),
Tg2576/Synj+/+ (n=8), and Tg2576/Synj1+/− (n=12) mice. B, Freezing responses in the
auditory cued FC with the mice used in (A) C, Two-day RAWM. WT (n=9), Synj1+/− (n=9),
Tg2576/Synj1+/+ (n=8) and Tg2576/Synj1+/− (n=9) D, Visible platform test; WT (n=9),
Synj1+/− (n=9), Tg2576/Synj1+/+ (n=7) and Tg2576/Synj1+/− (n=9). E, Swim speed;WT
(n=9), Synj1+/− (n=9), Tg2576/Synj1+/+ (n=7) and Tg2576/Synj1+/− (n=9). F, NOR training;
WT (n=9), Synj1+/− (n=9), Tg2576/Synj1+/+ (n=7), and Tg2576/Synj1+/− (n=9). Exploration
time is expressed by Novel Object Discrimination (NOD) Index = amount of time spent
exploring novel object *100 / time exploring novel object + time exploring familiar object.
G, NOR testing. H, The hyperlocomotor activity displayed by mice tested in NOR.
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APP and Aβ levels are not significantly altered by reduction of Synj1 in Tg2576 mice. A,
Western blot detection of human APP (6E10), Synj1 and anti-neuronal β-tubulin (TUJ1)
from brain of WT (n=6), Synj1+/− (n=7), Tg2576/Synj1+/+ (n=5) and Tg2576/Synj1+/− (n=7)
mice. B, APP levels as normalized to TUJ1. C, Synj1 levels as normalized to TUJ1. D,
Detection of Aβ42 and Aβ40 from brain of Tg2576/Synj1+/+ (n=5) and Tg2576/Synj1+/−
(n=7) mice. E, Inositol lipid levels from synaptosome-enriched (P2) fractions derived from
forebrain tissue of WT (n=9), Synj1+/− (n=6), Tg2576/Synj1+/+ (n=6) and Tg2576/Synj1+/−
(n=6) mice, as determined by HPLC combined with suppressed conductivity.
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Alterations of spine morphology attributed to Aβ are ameliorated with reduction of Synj1.
A, Dendritic spines in hippocampal neuronal neuronsexposed to 200nM Aβ oligomer (o Aβ)
for 24 hours and DiOlistically labeled from WT(+/+) cultures (n=4): DMSO treated (n=22)
and o Aβ treated (n=21); Synj1+/− (+/−) cultures(n=4):DMSO treated (n=22) and o Aβ
treated (n=20); or Synj1−/− (−/−) cultures(n=3):DMSO treated (n=19) and o Aβ treated
(n=19); Bar 10μm. B, Spine density. C, Spine length. D, Spine head diameter. E, Spine
class analysis using Neuron Studio which distinguishes spine classes on basis of length and
presence of a spine head. Mushroom, stubby and thin are less than 2μm while long spines
and filopodiaare more than 2μm long. Mushroom and long spines have a head, while the
other classes do not. The total number of spines analyzed was 3,745 for 7,415μm length of
dendriteas follows: Synj1+/+ (DMSO: 758; oAβ: 414); Synj1+/− (DMSO: 722; oAβ: 408);
Synj1−/− (DMSO: 686; Aβ: 757).
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